Cabazitaxel Acetone Solvate is a crystalline form of the anticancer drug cabazitaxel, in which the drug is co-crystallized with acetone. This solvate form may be used during manufacturing or formulation to enhance properties like stability, purity, or processability, but it still delivers the same active compound, cabazitaxel, once administered. It is grouped under the following drug class(es): Microtubule inhibitors, Taxanes and Terpenes. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Jevtana (TN) and Cabazitaxel acetonate (JAN). Its PubChem CID is 72734356.
Cabazitaxel acetone
| CAS No | 1426815-65-7 |
|---|---|
| Molecular Formula | C48H63NO15 |
| Molecular Weight | 894.0 g/mol |
| Synonyms | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;propan-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cabazitaxel Acetone Solvate is a crystalline form of the anticancer drug cabazitaxel, in which the drug is co-crystallized with acetone.
The listed CAS number is 1426815-65-7.
The listed molecular formula is C48H63NO15.
The listed molecular weight is 894.0 g/mol.
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;propan-2-one.
The source lists Jevtana (TN) and Cabazitaxel acetonate (JAN).